drugset / Trial / NCT00236873

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

NCT00236873

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy and safety of topiramate in epilepsy patients with difficult to treat, partial-onset seizures who are taking one or two standard antiepileptic drugs.

Timeline

Start
1989-10
Primary completion
Completion
1993-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 400 mg Oral

Indications